345 related articles for article (PubMed ID: 22231906)
1. Circulating microRNAs involved in multiple sclerosis.
Siegel SR; Mackenzie J; Chaplin G; Jablonski NG; Griffiths L
Mol Biol Rep; 2012 May; 39(5):6219-25. PubMed ID: 22231906
[TBL] [Abstract][Full Text] [Related]
2. Identification of the miRNA-mRNA regulatory network in multiple sclerosis.
Yang Q; Pan W; Qian L
Neurol Res; 2017 Feb; 39(2):142-151. PubMed ID: 27809691
[TBL] [Abstract][Full Text] [Related]
3. Selected extracellular microRNA as potential biomarkers of multiple sclerosis activity--preliminary study.
Kacperska MJ; Jastrzebski K; Tomasik B; Walenczak J; Konarska-Krol M; Glabinski A
J Mol Neurosci; 2015 May; 56(1):154-63. PubMed ID: 25487315
[TBL] [Abstract][Full Text] [Related]
4. Expression, regulation and function of microRNAs in multiple sclerosis.
Ma X; Zhou J; Zhong Y; Jiang L; Mu P; Li Y; Singh N; Nagarkatti M; Nagarkatti P
Int J Med Sci; 2014; 11(8):810-8. PubMed ID: 24936144
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood.
Cox MB; Cairns MJ; Gandhi KS; Carroll AP; Moscovis S; Stewart GJ; Broadley S; Scott RJ; Booth DR; Lechner-Scott J;
PLoS One; 2010 Aug; 5(8):e12132. PubMed ID: 20711463
[TBL] [Abstract][Full Text] [Related]
6. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.
Regev K; Healy BC; Khalid F; Paul A; Chu R; Tauhid S; Tummala S; Diaz-Cruz C; Raheja R; Mazzola MA; von Glehn F; Kivisakk P; Dupuy SL; Kim G; Chitnis T; Weiner HL; Gandhi R; Bakshi R
JAMA Neurol; 2017 Mar; 74(3):275-285. PubMed ID: 28114622
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
Vistbakka J; Elovaara I; Lehtimäki T; Hagman S
Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells.
Sanders KA; Benton MC; Lea RA; Maltby VE; Agland S; Griffin N; Scott RJ; Tajouri L; Lechner-Scott J
Clin Epigenetics; 2016; 8(1):87. PubMed ID: 27570566
[TBL] [Abstract][Full Text] [Related]
9. Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study.
Gonzalez-Martinez A; Bose G; Lokhande H; Saxena S; Healy BC; Polgar-Turcsanyi M; Weiner HL; Chitnis T
J Neuroinflammation; 2023 Jun; 20(1):136. PubMed ID: 37264432
[TBL] [Abstract][Full Text] [Related]
10. Genetic association and altered gene expression of mir-155 in multiple sclerosis patients.
Paraboschi EM; Soldà G; Gemmati D; Orioli E; Zeri G; Benedetti MD; Salviati A; Barizzone N; Leone M; Duga S; Asselta R
Int J Mol Sci; 2011; 12(12):8695-712. PubMed ID: 22272099
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy-Induced Changes in microRNA Expression in Multiple Sclerosis.
Søndergaard HB; Airas L; Christensen JR; Nielsen BR; Börnsen L; Oturai A; Sellebjerg F
Front Immunol; 2020; 11():552101. PubMed ID: 33584638
[TBL] [Abstract][Full Text] [Related]
12. Potential Value of miR-23a for Discriminating Neuromyelitis Optica Spectrum Disorder from Multiple Sclerosis.
Sharaf-Eldin W; Kishk N; Sakr B; El-Hariri H; Refeat M; ElBagoury N; Essawi M
Arch Iran Med; 2020 Oct; 23(10):678-687. PubMed ID: 33107309
[TBL] [Abstract][Full Text] [Related]
13. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis.
Takahashi I; Hama Y; Matsushima M; Hirotani M; Kano T; Hohzen H; Yabe I; Utsumi J; Sasaki H
Mol Brain; 2015 Oct; 8(1):67. PubMed ID: 26497046
[TBL] [Abstract][Full Text] [Related]
14. Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-β.
De Felice B; Mondola P; Sasso A; Orefice G; Bresciamorra V; Vacca G; Biffali E; Borra M; Pannone R
BMC Med Genomics; 2014 May; 7():26. PubMed ID: 24885345
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis.
Thamilarasan M; Koczan D; Hecker M; Paap B; Zettl UK
Autoimmun Rev; 2012 Jan; 11(3):174-9. PubMed ID: 21621006
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
Gandhi R; Healy B; Gholipour T; Egorova S; Musallam A; Hussain MS; Nejad P; Patel B; Hei H; Khoury S; Quintana F; Kivisakk P; Chitnis T; Weiner HL
Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of translational regulation by microRNAs in multiple sclerosis.
Junker A
FEBS Lett; 2011 Dec; 585(23):3738-46. PubMed ID: 21453702
[TBL] [Abstract][Full Text] [Related]
18. MiR-422a as a potential cellular microRNA biomarker for postmenopausal osteoporosis.
Cao Z; Moore BT; Wang Y; Peng XH; Lappe JM; Recker RR; Xiao P
PLoS One; 2014; 9(5):e97098. PubMed ID: 24820117
[TBL] [Abstract][Full Text] [Related]
19. miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS.
Rhead B; Shao X; Graves JS; Chitnis T; Waldman AT; Lotze T; Schreiner T; Belman A; Krupp L; Greenberg BM; Weinstock-Guttman B; Aaen G; Tillema JM; Rodriguez M; Hart J; Caillier S; Ness J; Harris Y; Rubin J; Candee MS; Gorman M; Benson L; Mar S; Kahn I; Rose J; Casper TC; Quach H; Quach D; Schaefer C; Waubant E; Barcellos LF;
Ann Clin Transl Neurol; 2019 Jun; 6(6):1053-1061. PubMed ID: 31211169
[TBL] [Abstract][Full Text] [Related]
20. MiR-126: a novel route for natalizumab action?
Meira M; Sievers C; Hoffmann F; Derfuss T; Kuhle J; Kappos L; Lindberg RL
Mult Scler; 2014 Sep; 20(10):1363-70. PubMed ID: 24598267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
